Dennis P West

  • 5767 Citations
1977 …2022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dermatopharmacology

Training Experience

1968Residency, University of Chicago

Education/Academic qualification

PhD, Pacific Western University

… → 1993

Keywords

  • Clinical Pharmacology
  • Clinical Trial Methodology
  • Dermatology
  • Drug Discovery
  • Drugs (clinical pharmacology)
  • Pharmacology
  • Pharmacovigilance
  • Quality of Life

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Drug-Related Side Effects and Adverse Reactions Medicine & Life Sciences
Skin Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Minoxidil Medicine & Life Sciences
Psoriasis Medicine & Life Sciences
United States Food and Drug Administration Medicine & Life Sciences
Skin Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2001 2022

Research Output 1977 2019

Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

Kelm, R. C., Hagstrom, E. L., Mathieu, R. J., Orrell, K. A., Serrano, L., Mueller, K. A., Laumann, A. E., West, D. P. & Nardone, B., Mar 1 2019, In : Journal of the American Academy of Dermatology. 80, 3, p. 820-821 2 p.

Research output: Contribution to journalArticle

Drug-Related Side Effects and Adverse Reactions
Melanoma
Research
Natalizumab

Reply to: “Aspirin use and the risk of malignant melanoma”

Orrell, K. A., Rademaker, A. W., West, D. P. & Nardone, B., Jan 1 2019, In : Journal of the American Academy of Dermatology. 80, 1, p. e15

Research output: Contribution to journalLetter

Aspirin
Melanoma

Vulvar cancer association with groin hidradenitis suppurativa: A large, urban, midwestern US patient population study

Rastogi, S., Patel, K. R., Singam, V., Ali, Y., Gao, J., Amin, A. Z., Schlosser, B. J., West, D. P. & Nardone, B., Mar 1 2019, In : Journal of the American Academy of Dermatology. 80, 3, p. 808-810 3 p.

Research output: Contribution to journalArticle

Hidradenitis Suppurativa
Vulvar Neoplasms
Groin
Population

Blinatumomab and pancreatitis: an analysis of FAERS, EudraVigilance, and a large urban U.S. patient population data

Vakharia, P., Nardone, B., Budris, W., Hoshizaki, K., Frankfurt, O. & West, D. P., Jul 3 2018, In : Leukemia and Lymphoma. 59, 7, p. 1759-1761 3 p.

Research output: Contribution to journalEditorial

Pancreatitis
Population
blinatumomab
4 Citations (Scopus)

Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry

Siegfried, E. C., Jaworski, J. C., Eichenfield, L. F., Paller, A., Hebert, A. A., Simpson, E. L., Altman, E., Arena, C., Blauvelt, A., Block, J., Boguniewicz, M., Chen, S., Cordoro, K., Hanna, D., Horii, K., Hultsch, T., Lee, J., Leung, D. Y., Lio, P. A., Milner, J. & 13 othersOmachi, T., Schneider, C., Schneider, L., Sidbury, R., Smith, T., Sugarman, J., Taha, S., Tofte, S., Tollefson, M., Tom, W. L., West, D. P., Whitney, L. & Zane, L., May 1 2018, In : Pediatric Dermatology. 35, 3, p. 303-322 20 p.

Research output: Contribution to journalArticle

Atopic Dermatitis
Industry
United States Food and Drug Administration
Clinical Trials
Pharmaceutical Preparations